B. Riley Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

B. Riley Wealth Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,132	Closed	-$383K	–	1503
2021 Q1	$383K	Sell	2,132 -405	-16%	-$76.1K	0.01%	863
2020 Q4	$294K	Buy	+2,537	New	+$284K	0.02%	765
2019 Q3	–	Sell	-1,194	Closed	-$207K	–	869
2019 Q2	$207K	Sell	1,194 -261	-18%	-$45.1K	0.02%	706
2019 Q1	$246K	Buy	+1,455	New	+$217K	0.03%	580
2018 Q4	–	Sell	-1,601	Closed	-$277K	–	759
2018 Q3	$277K	Buy	+1,601	New	+$231K	0.03%	523
2015 Q1	–	Sell	-330	Closed	-$22	–	2204
2014 Q4	$22	Buy	+330	New	+$24.1K	﹤0.01%	2511

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

B. Riley Wealth Advisors's GWPH Position: Q2 2021 in Review

B. Riley Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,132 shares — an estimated $383K sold.

B. Riley Wealth Advisors first reported a position in GWPH in Q4 2014 and held it in 6 quarters. The position peaked at $383K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

B. Riley Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
B. Riley Wealth Advisors sold 2,132 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $383K.
B. Riley Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 6 quarters.
B. Riley Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $383K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.